Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chris Coppin. (2008) Immunotherapy for renal cell cancer in the era of targeted therapy. Expert Review of Anticancer Therapy 8:6, pages 907-919.
Read now
Read now
Articles from other publishers (36)
Muhammad Majdoub, Takafumi Yanagisawa, Fahad Quhal, Ekaterina Laukhtina, Markus von Deimling, Tatsushi Kawada, Pawel Rajwa, Alberto Bianchi, Maximilian Pallauf, Hadi Mostafaei, Marcin Chlosta, Benjamin Pradere, Pierre I. Karakiewicz, Manuela Schmidinger, Ronen Rub & Shahrokh F. Shariat. (2023) Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non‐metastatic renal cell carcinoma: Systematic review and meta‐analysis. International Journal of Cancer.
Crossref
Crossref
Mustafa Wasifuddin, Danelly J Gomez D' Aza, Akriti Pokhrel, Kapilkumar Manvar & Jen Chin Wang. (2023) Recurrent Left Renal Fossa Clear Cell Renal Cell Carcinoma With Pancreatic Tail Invasion Presenting as Intestinal Obstruction. Cureus.
Crossref
Crossref
Mattia L. Piccinelli, Stefano Tappero, Cristina Cano Garcia, Francesco Barletta, Reha-Baris Incesu, Simone Morra, Lukas Scheipner, Zhe Tian, Stefano Luzzago, Francesco A. Mistretta, Matteo Ferro, Fred Saad, Shahrokh F. Shariat, Sascha Ahyai, Nicola Longo, Derya Tilki, Alberto Briganti, Felix K.H. Chun, Carlo Terrone, Ottavio de Cobelli, Gennaro Musi & Pierre I. Karakiewicz. (2023) Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma. European Urology Open Science 53, pages 109-115.
Crossref
Crossref
Mariaconsiglia Ferriero, Loris Cacciatore, Mario Ochoa, Riccardo Mastroianni, Gabriele Tuderti, Manuela Costantini, Umberto Anceschi, Leonardo Misuraca, Aldo Brassetti, Salvatore Guaglianone, Alfredo Maria Bove, Rocco Papalia, Michele Gallucci & Giuseppe Simone. (2023) The Impact of Metastasectomy on Survival Outcomes of Renal Cell Carcinoma: A 10-Year Single Center Experience. Cancers 15:13, pages 3332.
Crossref
Crossref
Federica Cosso, Giandomenico Roviello, Gabriella Nesi, Sonia Shabani, Pietro Spatafora, Donata Villari & Martina Catalano. (2023) Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?. International Journal of Molecular Sciences 24:4, pages 4243.
Crossref
Crossref
Konstantinos Drosos, Karsten Fischer, Guido Rieck & Tilmann Kälble. (2020) Retrovesikales Rezidiv eines Nierenzellkarzinoms 14 Jahre nach laparoskopischer Nephrektomie. Ein Fallbericht. Aktuelle Urologie 53:05, pages 443-447.
Crossref
Crossref
Thomas Powles, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Stefan N Symeonides, Jaroslav Hajek, Howard Gurney, Yen-Hwa Chang, Jae Lyun Lee, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross-Goupil, Mauricio Mahave, Naomi B Haas, Piotr Sawrycki, Joseph E Burgents, Lei Xu, Kentaro Imai, David I Quinn, Toni K Choueiri, Piotr Tomczak, Toni Choueiri, Se Hoon Park, Balaji Venugopal, Thomas R. Ferguson, Jaroslav Hajek, Tzu-Ping Lin, Stefan N. Symeonides, Jae Lyun Lee, Piotr Sawrycki, Naomi B. Haas, Howard P. Gurney, Mauricio Mahave, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross-Goupil, Christine Chevreau, John M. Burke, Gurjyot Doshi, Bohuslav Melichar, Delphine Topart, Stephane Oudard, Evgeniy Kopyltsov, Hans-Joerg Hammers, David I. Quinn, Ajjai Alva, Juliana de Janoski Menezes, Adriano Goncalves e Silva, Eric W. Winquist, Alketa Hamzaj, Giuseppe Procopio, Boguslawa Karaszewska, Ewa M. Nowakowska-Zajdel, Boris Y. Alekseev, Rustem A. Gafanov, Adel Izmailov, Andrey Semenov, Sergey G. Afanasyev, Oleg N. Lipatov, Thomas B. Powles, Sandy Srinivas, David McDermott, Samith T. Kochuparambil, Ian D. Davis, Katriina Peltola, Roberto Sabbatini, Jinsoo Chung, Michail I. Shkolnik, Vsevolod B. Matveev, Pablo Gajate Borau, Steven McCune, Thomas E. Hutson, Alejandro Dri, Silvio Correia Sales, Carrie Yeung, Carmen Marcela Alcala Castro, Peter Bostrom, Brigitte Laguerre, Consuelo Buttigliero, Ugo de Giorgi, Eugeniy A. Fomin, Yousef Zakharia, Clara Hwang, Eric A. Singer, Jeffrey T. Yorio, David Waterhouse, Ruben Dario Kowalyszyn, Margarita Sonia Alfie, Eduardo Yanez Ruiz, Tomas Buchler, Krista Kankaanranta, Gianluigi Ferretti, Go Kimura, Kazuo Nishimura, Naoya Masumori, Satoshi Tamada, Haruaki Kato, Hiroshi Kitamura, Iwona Danielewicz, Joanna Wojcik-Tomaszewska, Nuria Sala Gonzalez, Kun-Yuan Chiu, Michael B. Atkins, Elisabeth Heath, Gustavo Adolfo Rojas-Uribe, Manuel Enrique Gonzalez Fernandez, Susan Feyerabend, Sandro Pignata, Kazuyuki Numakura, Bozena Cybulska Stopa, Ruslan Zukov, Miguel Angel Climent Duran, Pablo Jose Maroto Rey, Alvaro Montesa Pino, Chao-Hsiang Chang, Salil Vengalil, Tom S. Waddell, Patrick W. Cobb, Ralph Hauke, Daniel M. Anderson, John Sarantopoulos, Theodore Gourdin, Tian Zhang, Gautam Jayram, Luis Enrique Fein, Carole Harris, Patricia Medeiros Milhomem Beato, Francisco Flores, Angela Estay, Juan Andres Rubiano, Jens Bedke, Stefan Hauser, Andreas Neisius, Jonas Busch, Satoshi Anai, Hiroyuki Tsunemori, Dariusz Sawka, Bozena Sikora-Kupis, Jose Angel Arranz, Ignacio Delgado, Chung-Hsin Chen, Elizabeth Gunderson, Scott Tykodi, Alan Koletsky, Kevin Chen, Manish Agrawal, Diego Lucas Kaen, Juan Pablo Sade, Marcelo Daniel Tatangelo, Francis Parnis, Fernando Maciel Barbosa, Genevieve Faucher, Nayyer Iqbal, Daniele Marceau, Jean-Benoit Paradis, Nawar Hanna, Alejandro Acevedo, Carolina Ibanez, Luis Villanueva, Pedro Pablo Galaz, Isabel Cristina Durango, Ray Manneh, Zdenek - Kral, Petra Holeckova, Heikki Hakkarainen, Hanna Ronkainen, Sophie Abadie-Lacourtoisie, Sophie Tartas, Peter J. Goebell, Marc-Oliver Grimm, Thomas Hoefner, Manfred Wirth, Andrej Panic, Wolfgang Schultze-Seemann, Akira Yokomizo, Ryuichi Mizuno, Hirotsugu Uemura, Masatoshi Eto, Masao Tsujihata, Yoshihisa Matsukawa, Yoji Murakami, Miso Kim, Paul Hamberg, Malgorzata Marczewska-Skrodzka, Cezary Szczylik, Alison C. Humphreys, Peter Jiang, Birendra Kumar, Gary Lu, Arpita Desai, Jose Antonio Karam, George Keogh, Mark Fleming, Juan Jose Zarba, Viviana E. Leiva, Guillermo Ariel Mendez, Samuel J. Harris, Stephen J. Brown, Joao Neif Antonio Junior, Rita de Cassia Costamilan, Roberto Odebrecht Rocha, David Muniz, Leandro Brust, Aly-Khan Lalani, Jeffrey Graham, Michael Levesque, Francisco Orlandi, Rostislav Kotasek, Jean L. Deville, Delphine Borchiellini, Axel Merseburger, Michael Rink, Frederik Roos, Ray McDermott, Masafumi Oyama, Yoshiaki Yamamoto, Yoshihiko Tomita, Yuji Miura, Naomasa Ioritani, Hans Westgeest, Tomasz Kubiatowski, Wieslaw Bal, Regina Girones Sarrio, Julie Rowe, Debra M. Prow, Francis Senecal, Neda Hashemi-Sadraei, Scott W. Cole, Stephan D. Kendall, Donald A. Richards, Ian D. Schnadig & Mukul Gupta. (2022) Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology 23:9, pages 1133-1144.
Crossref
Crossref
Simon Juul, Frede Donskov, Peter E Clark, Lars Lund & Nessn H Azawi. (2022) GRade, Age, Nodes, and Tumor (GRANT) compared with Leibovich score to predict survival in localized renal cell carcinoma: A nationwide study. International Journal of Urology 29:7, pages 641-645.
Crossref
Crossref
Hannah Dzimitrowicz, Elizabeth Esterberg, LaStella Miles, Giovanni Zanotti, Azah Borham & Michael R. Harrison. (2021) Referral and adjuvant treatment patterns after nephrectomy in high‐risk locoregional renal cell carcinoma. Cancer Medicine 10:24, pages 8891-8898.
Crossref
Crossref
Yasmin Abu‐Ghanem, Thomas Powles, Umberto Capitanio, Christian Beisland, Petrus Järvinen, Grant D. Stewart, Eirikur Gudmundsson, Thomas B.L. Lam, Lorenzo Marconi, Sergio Fernandéz‐Pello, Harry Nisen, Richard P. Meijer, Alessandro Volpe, Börje Ljungberg, Tobias Klatte, Karim Bensalah, Saeed Dabestani & Axel Bex. (2021) Should patients with low‐risk renal cell carcinoma be followed differently after nephron‐sparing surgery vs radical nephrectomy?. BJU International 128:3, pages 386-394.
Crossref
Crossref
Yasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio, Christian Beisland, Petrus Järvinen, Grant D. Stewart, Eiríkur Orri Gudmundsson, Thomas B. Lam, Lorenzo Marconi, Sergio Fernandéz-Pello, Harry Nisen, Richard P. Meijer, Alessandro Volpe, Börje Ljungberg, Tobias Klatte, Saeed Dabestani & Axel Bex. (2021) The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery—Results from RECUR Consortium. European Urology Oncology 4:3, pages 473-482.
Crossref
Crossref
Irina Zh. Shubina, Irina O. Chikileva, Igor V. Samoylenko & Mikhail V. Kiselevskiy. 2021. Cancer Immunology. Cancer Immunology
25
39
.
Megan M. Merrill & Jose A. Karam. 2020. Renal Cancer. Renal Cancer
361
386
.
Andrew G. McIntosh, Eric C. Umbreit & Christopher G. Wood. 2020. Renal Cancer. Renal Cancer
295
305
.
Wei Wang, Wentao Hu, Ya Wang, Jing Yang & Zhongjin Yue. (2019) MicroRNA‑508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion. Experimental and Therapeutic Medicine.
Crossref
Crossref
Maxine Sun, Malte Vetterlein, Lauren C. Harshman, Steven L. Chang, Toni K. Choueiri & Quoc-Dien Trinh. (2017) Risk Assessment in Small Renal Masses. Urologic Clinics of North America 44:2, pages 189-202.
Crossref
Crossref
Si-Ming WEI, Hang-Li PAN, Li WANG, Guo-Li YIN, Kai ZHONG, Ya ZHOU, Shu-Jiao YANG & Zhao-Liang XIN. (2017) Combination therapy with dendritic cell-based vaccine and anti-CD69 antibody enhances antitumor efficacy in renal cell carcinoma-bearing mice. TURKISH JOURNAL OF MEDICAL SCIENCES 47, pages 658-667.
Crossref
Crossref
Antony Joseph. 2017. Investigating Seafloors and Oceans. Investigating Seafloors and Oceans
493
554
.
Stefano Ricciardulli, Qiang Ding, Xu Zhang, Hongzhao Li, Baojun Wang, Guoqiang Yang, Xiyou Wang, Peng Zhang, Xin Ma & Alberto Breda. (2016) Evaluation of PADUA Score as Predictor of Warm Ischemia Time (WIT) during Laparoscopic Partial Nephrectomy (LPN). Urologia Journal 83:4, pages 194-199.
Crossref
Crossref
Jagtar Singh, Rama Jayaraj, Siddhartha Baxi, Mariana Mileva, John Skinner, Navneet Dhand & Mahiban Thomas. (2015) Immunohistochemical expression levels of p53�and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma. Molecular and Clinical Oncology.
Crossref
Crossref
Myungsun Shim, Cheryn Song, Sejun Park, Aram Kim, Seung-Kwon Choi, Choung-Soo Kim & Hanjong Ahn. (2014) Hilar Location is an Independent Prognostic Factor for Recurrence in T1 Renal Cell Carcinoma After Nephrectomy. Annals of Surgical Oncology 22:1, pages 344-350.
Crossref
Crossref
Kathie Wong & Ben Challacombe. (2013) Better late than early for long-term survival in patients with recurrence after renal carcinoma. BJU International 112:7, pages 877-878.
Crossref
Crossref
J.-J. Patard, H. Baumert, K. Bensalah, J.-C. Bernhard, P. Bigot, B. Escudier, N. Grenier, J.-F. H?tet, J.-A. Long, A. M?jean, P. Paparel, S. Richard, N. Rioux-Leclercq, P. Coloby & M. Souli?. (2013) Recommandations en onco-urologie 2013 du CCAFU: Cancer du rein. Progr?s en Urologie 23, pages S177-S204.
Crossref
Crossref
Sabine Brookman-May, Matthias May, Shahrokh F. Shariat, Evanguelos Xylinas, Christian Stief, Richard Zigeuner, Thomas Chromecki, Maximilian Burger, Wolf F. Wieland, Luca Cindolo, Luigi Schips, Ottavio De Cobelli, Bernardo Rocco, Cosimo De Nunzio, Bogdan Feciche, Michael Truss, Christian Gilfrich, Sascha Pahernik, Markus Hohenfellner, Stefan Zastrow, Manfred P. Wirth, Giacomo Novara, Marco Carini, Andrea Minervini, Claudio Simeone, Alessandro Antonelli, Vincenzo Mirone, Nicola Longo, Alchiede Simonato, Giorgio Carmignani & Vincenzo Ficarra. (2013) Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project). European Urology 64:3, pages 472-477.
Crossref
Crossref
Sabine D. Brookman-May, Matthias May, Shahrokh F. Shariat, Giacomo Novara, Richard Zigeuner, Luca Cindolo, Ottavio De Cobelli, Cosimo De Nunzio, Sascha Pahernik, Manfred P. Wirth, Nicola Longo, Alchiede Simonato, Sergio Serni, Salvatore Siracusano, Alessandro Volpe, Giuseppe Morgia, Roberto Bertini, Orietta Dalpiaz, Christian Stief & Vincenzo Ficarra. (2013) Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma - results from a comprehensive multi-centre database (CORONA/SATURN-Project). BJU International, pages n/a-n/a.
Crossref
Crossref
Yun-Sok Ha, Yong Hyun Park, Seok Ho Kang, Sung-Hoo Hong, Tae-Kon Hwang, Seok-Soo Byun & Yong-June Kim. (2013) Predictive Factors for Late Recurrence in Patients With Stage T1 Clear Cell Renal Cell Carcinoma: A Multiinstitutional Study. Clinical Genitourinary Cancer 11:1, pages 51-55.
Crossref
Crossref
Paul Russo. 2013. Renal Cancer. Renal Cancer
307
322
.
Megan M. Merrill & Jose A. Karam. 2013. Renal Cancer. Renal Cancer
283
305
.
Lui Shiong Lee & Min-Han Tan. (2012) Predictive models for the practical management of renal cell carcinoma. Nature Reviews Urology 9:2, pages 73-84.
Crossref
Crossref
Hanna Ronkainen, Markku H. Vaarala, Pasi Hirvikoski & Ari Ristimäki. (2010) HuR expression is a marker of poor prognosis in renal cell carcinoma. Tumor Biology 32:3, pages 481-487.
Crossref
Crossref
Ari Adamy, Kian Tai Chong, Daher Chade, James Costaras, Grace Russo, Matthew G. Kaag, Melanie Bernstein, Robert J. Motzer & Paul Russo. (2011) Clinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell Carcinoma. Journal of Urology 185:2, pages 433-438.
Crossref
Crossref
J.-J. Patard, H. Baumert, J.-M. Corréas, B. Escudier, H. Lang, J.-A. Long, Y. Neuzillet, P. Paparel, L. Poissonnier, N. Rioux-Leclercq & M. Soulié. (2010) Recommandations en Onco-Urologie 2010 : Cancer du rein. Progrès en Urologie 20, pages S319-S339.
Crossref
Crossref
Nyree Griffin, Lee Alexander Grant, Nishat Bharwani & S. Aslam Sohaib. (2009) Computed Tomography in Metastatic Renal Cell Carcinoma. Seminars in Ultrasound, CT and MRI 30:4, pages 359-366.
Crossref
Crossref
Florian R Fritzsche, Kirsten Wassermann, Monika Jung, Angelika Tölle, Ilka Kristiansen, Michael Lein, Manfred Johannsen, Manfred Dietel, Klaus Jung & Glen Kristiansen. (2008) ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 8:1.
Crossref
Crossref
Adilson Prando. (2008) Achados da tomografia computadorizada em metástases pancreáticas do carcinoma de células renais. Radiologia Brasileira 41:4, pages 225-228.
Crossref
Crossref
John S Lam, Jonathan Bergman, Alberto Breda & Peter G Schulam. (2008) Importance of surgical margins in the management of renal cell carcinoma. Nature Clinical Practice Urology 5:6, pages 308-317.
Crossref
Crossref